sameAs
The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients.Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement.Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extensionStereotactic radiosurgery of pituitary adenomas.Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very-low-calorie diet.Intraoperative Magnetic Resonance Imaging During Endoscopic Transsphenoidal Surgery of Growth Hormone-Secreting Pituitary Adenomas.Expression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators.The role of apoptosis in pituitary adenomas in the field of conventionally used therapeutic approaches.Serum prolactin stress values in patients with systemic lupus erythematosus.Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.Use of the Leksell gamma knife in the treatment of prolactinoma patients.The effects of growth hormone status on circulating levels of vascular growth factors.Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas.Gamma knife radiosurgery for endocrine-inactive pituitary adenomasRegression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog)Long-term echocardiographic follow-up of acromegalic heart diseaseCephalometric assessment of cranial abnormalities in patients with acromegalyCyproheptadine in Cushing's syndromeBromocriptine and plasma-aldosteroneThe use of andriol in treatment of androgen deficiency in transsexual womenPharmacokinetics of oral terguride in patients with a prolactinomaEvidence for immunomodulatory properties of prolactin in selected in vitro and in vivo situationsIncrease of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacementIs it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife?Gamma knife radiosurgery for acromegaly--long-term experienceEndonasal endoscopic pituitary adenoma resection: preservation of neurohypophyseal functionDiagnosis and treatment of prolactinomasAminoglutethimide administration in pregnancy
P50
Q31097255-F6F3D09D-57B7-4C3C-A6B1-E730891098B7Q31108289-46D1E0DE-98C3-45AD-A15E-8554F3B17EAAQ32027204-CBA3C063-2992-48D9-81C9-C762BC9AE4FCQ33393235-53B7B07C-0B42-4F24-8229-74B6D43B7D08Q33595081-CE3DC118-CD95-4DB1-9107-BFAAF0B253D5Q38149167-0136C755-AF93-4D9A-B8BC-E813B4D02D8FQ38325713-14666A4F-FAC5-415F-A6DF-69D38062ABEAQ39790642-4F10BA3A-F49A-4944-93C7-23BC0219837BQ40275090-798A4C8B-44FB-4396-92B7-E202769C63C9Q40576073-F7341968-FA4B-40E8-AB0C-9EEBB161E8CEQ43050511-19769987-5450-4FDF-8F88-21C7F4A34B36Q44461588-9EFA542E-B9A3-40C1-B9D5-0B7618B0C861Q44791805-1A360BAC-9502-4907-A174-09014B2E08ABQ46190981-96F1743C-4611-4C96-8DFA-A384D763B106Q46424155-292531CA-A1C1-4C27-BDA5-A7ABDD354ABEQ53854399-9317E5C3-C376-4300-B43A-0B43C11E5335Q54372093-D0381191-655F-48BB-A5A1-D15DE6673F50Q57216379-AD28D24D-B415-4FF3-B70D-5B2D2CAD03ACQ57566885-A2D431FE-C9F8-4011-AB25-A40A00DEF60EQ57566892-2B9639AF-50B0-4967-A945-FF11DD0FFE82Q62851215-5C8D43C1-7BE9-456C-8314-9D4786DFDAAAQ66696320-7A46EDC7-4D91-4F27-93B3-033644AB14C9Q66706445-7386976B-2AAF-4DC3-8FFE-2F4AB6C1C1CCQ69496568-92FC5A44-AE35-43BD-AFC7-2FECBC216B3CQ69568492-DC651008-4418-48E0-9056-808BBFE66F3AQ70231057-D4EA1CE0-B6B4-4B30-8EA5-469946475141Q73738552-E17A812B-1B8F-44E0-B786-AA547FFAA53FQ82430529-40A45A38-8D28-4144-B61E-3684D925E118Q83225672-15E7340C-9D13-4B3C-AB54-359403A1668CQ87560631-4CBE3A1D-C3CF-4527-A7DB-87E168A5163FQ91710402-84FD5CE4-99CD-4C18-AD80-F8A51930F213Q93693891-87EF97F5-DEAA-4771-96B5-240F8537C896
P50
description
Czech internist, endocrinologist and academic
@en
dokter
@id
pedagoog
@nl
český internista, endokrinolog a profesor lékařství
@cs
name
Josef Marek
@ast
Josef Marek
@cs
Josef Marek
@de
Josef Marek
@en
Josef Marek
@es
Josef Marek
@nl
Josef Marek
@pl
Josef Marek
@sq
type
label
Josef Marek
@ast
Josef Marek
@cs
Josef Marek
@de
Josef Marek
@en
Josef Marek
@es
Josef Marek
@nl
Josef Marek
@pl
Josef Marek
@sq
prefLabel
Josef Marek
@ast
Josef Marek
@cs
Josef Marek
@de
Josef Marek
@en
Josef Marek
@es
Josef Marek
@nl
Josef Marek
@pl
Josef Marek
@sq
P106
P214
P227
P269
P109
P1153
55653067700
P1207
n2006090332
P19
P21
P213
0000 0001 0920 7903
P214
P227
1042853215
P269
P31
P496
0000-0002-3257-2025
P569
1936-01-23T00:00:00Z
P570
2019-10-22T00:00:00Z
P691
nlk19990073526